Global pharmaceutical companies lose an estimated $75 billion annually to prescription drug counterfeits — not including costs of diminished brand value.
Impending government regulations will require comprehensive serialization not just in manufacturing facilities, but also across the supply chain.
In this webinar Rockwell Automation offers the opportunity to discuss important aspects related to the adoption of a serialization and aggregation solution, including
The session will then enter a deeper analysis of the benefits available beyond compliance:
The webinar will close with examples of customers successful implementations, related challenges and results.
View the discussion thread.